$RXO

RXO, Inc. (RXO): Results of Operations and Financial Condition

RXO, Inc. (RXO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rxo2026q2pressrelease.htm EX-99.1 Document Exhibit 99.1 Market Share Gains and Improved Profitability Drive Strong Second-Quarter Results for RXO • Full truckload volume improved every month and grew by 2% year over year in the second quarter, outperforming the market.

Original reporting
Published Aug 6, 2026, 10:31 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:35 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RXO
Bullish
high confidence
Mentioned
$RXO
Relevance
9/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RXOBullishHigh
01

Why it matters

The key tradable items are the reported 2Q profitability metrics (gross profit per load growth, adjusted EBITDA) and the quantified 3Q adjusted EBITDA guidance range, alongside directional expectations for brokerage volume and truckload gross profit per load.

02

Market read

Traders can reprice RXO based on the combination of sequential profitability improvement and the new 3Q adjusted EBITDA range.

03

What to watch

Adjusted EBITDA margin is also down year over year (2.3% vs 2.7%), and the outlook is a range, so traders may focus on downside risk to the low end ($35M) if volume growth disappoints.

Relevance 9/10Novelty 9/10Timing: today’s 2Q results and 3Q adjusted EBITDA outlook (conference call at 8 a.m. ET)

Background

This is an SEC 8-K with Exhibit 99.1 covering RXO’s 2Q 2026 results and 3Q 2026 outlook.

Company-level read

Ticker impact

$RXOBullishHigh confidence
Context

RXO reported 2Q results and guided 3Q adjusted EBITDA to $35M-$45M, citing sequential truckload gross profit per load growth.

Expected impact

Likely positive near-term bias if investors focus on the sequential gross profit per load improvement and the $35M-$45M EBITDA outlook.

Evidence & confidence

The filing includes specific 2Q financials (revenue, margins, adjusted EBITDA) and a concrete 3Q adjusted EBITDA range plus directional volume and gross profit per load expectations.

Market effects

Signals improving profitability dynamics in asset-light trucking brokerage, potentially supporting sentiment for freight brokers with similar spot-mix exposure.

Limited, as the disclosure is company-specific rather than regional demand data.

Low, since the drivers are internal mix, volume, and freight under management rather than global macro shocks.

Counterpoint

Gross margin fell year over year (13.9% vs 17.8%), so the market may question whether the sequential improvement is enough to offset broader margin pressure.

Key entities

  • RXO, Inc.

    Asset-light transportation solutions provider reporting 2Q results and issuing 3Q adjusted EBITDA guidance.

  • Drew Wilkerson

    Chairman and CEO commenting on brokerage outperformance, spot mix, and complementary services momentum.

Related articles

$RXOMed

First look: mixed performance at RXO with some strong points

RXO reported mixed results for Q2 2026. GAAP net income per share was a 5-cent loss, versus a 21-cent loss in Q1, and adjusted EBITDA rose to $40 million from $38 million a year ago but fell in margin to 2.3%. RXO cited improved truckload spot mix and projected Q3 adjusted EBITDA of $35 to $45 million.

$CHRWMed

Trucking Stocks Fall on Legal Risk in Worst Month Since Tariffs

Trucking and logistics stocks are set for their worst month in over a year as legal risk rises after a Dallas County jury preliminary verdict against CH Robinson Worldwide, tied to a May Supreme Court ruling that may enable lawsuits against brokers for injuries from motor carriers. CH Robinson shares are down 21% this month; RXO and Landstar also fell amid weak earnings and outlooks.

$RXOMed

This trucking stock has doubled in 2026. BMO says it has more room to run

BMO Capital Markets initiated coverage of RXO with an Outperform rating and a $35 price target, implying 29% upside from Monday’s close. BMO cites tighter truckload conditions and expects RXO to reach about $600 million peak adjusted EBITDA by end-2028 versus $292 million consensus. RXO reports Q2 earnings in early August.